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Most substances can crystallise into two or more different crystal lattices, called polymorphs. Despite this,
there are no systems in which we can quantitatively predict the probability of one competing polymorph
forming, instead of the other. We address this problem using large scale (hundreds of events) studies of the
competing nucleation of the alpha and gamma polymorphs of glycine. In situ Raman spectroscopy is used to
identify the polymorph of each crystal. We find that the nucleation kinetics of the two polymorphs is very
different. Nucleation of the alpha polymorph starts off slowly but accelerates, while nucleation of the gamma
polymorph starts off fast but then slows. We exploit this difference to increase the purity with which we
obtain the gamma polymorph by a factor of ten. The statistics of the nucleation of crystals is analogous to
that of human mortality, and using a result from medical statistics we show that conventional nucleation data
can say nothing about what, if any, are the correlations between competing nucleation processes. Thus we
can show that, with data of our form, it is impossible to disentangle the competing nucleation processes. We
also find that the growth rate and the shape of a crystal depends on when it nucleated. This is new evidence
that nucleation and growth are linked.
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I. INTRODUCTION
Most molecules can crystallise into more than one crys-
tal lattice, these crystal structures are called polymorphs
of that molecule. A crystal’s polymorph defines its prop-
erties, and so polymorph control is crucial for intended
applications. For pharmaceuticals, polymorph control is
also required by regulators; without it a crystalline drug
cannot be sold1,2. We have almost no understanding of
why one polymorph forms and not another. We cannot
directly observe the process of crystal nucleation, and we
have very little quantitative data on the nucleation of
competing polymorphs. Here, we provide quantitative
nucleation data, use that data to predict how to improve
polymorph purity, and successfully test this prediction.
We also study crystal growth, and find that its rate de-
pends on nucleation time; crystals of a given polymorph
that nucleate at late times are different from those that
nucleate at early times. This observation of a link be-
tween crystal properties and nucleation time is novel,
and potentially allows the control of crystal properties
via nucleation.
Our work is a contribution to a growing literature
that studies nucleation quantitatively4–12. In a previ-
ous publication,10, we measured glycine’s nucleation rate
but did not quantitatively study the competition between
glycine’s polymorphs. All earlier quantitative work on
crystal nucleation, with the exception of that of Diao et
al.5, did not consider polymorphism. Diao et al.5 studied
the polymorphs of a molecule called ROY and found that
a)Electronic mail: r.sear@surrey.ac.uk
one polymorph dominated nucleation at early times, but
competing polymorphs were more likely to nucleate at
later times.
We report the results of large-scale (hundreds of nu-
cleation events), quantitative studies of the nucleation of
crystals of glycine. As nucleation is a random process,
studying just one sample is not enough to characterise
a nucleation rate4. So we and others study hundreds
of samples4,9,10, at each set of conditions. The novelty
in our approach lies in our combination of Raman spec-
troscopy to identify the polymorph of each crystal in situ,
with models taken from medical statistics. We show that
the statistics of nucleation, and the statistics of mortal-
ity are analogous. Both nucleation and death are irre-
versible processes, and both can have multiple causes,
polymorphs in the case of crystal nucleation, competing
mortality causes such as lung cancer, heart disease, etc,
in the case of death.
A. Previous work on glycine
We choose glycine because it is a well studied
model system for studies of nucleation of crystals from
solution2,3,6,10,12,13,16–28. Glycine has three polymorphs:
α, γ and β. α glycine is the most common poly-
morph to crystallise from aqueous solution at neutral pH,
but the γ polymorph is the most stable of the glycine
polymorphs29. The β polymorph is the least stable.
Adding salt favours the γ polymorph3,13,16,17,30.
Glycine also has the advantage that the α and γ poly-
morphs have clearly different Raman spectra5,9,33, in par-
ticular in the spectral region between 100 and 200 cm−1,
as we can see in Fig. 1(a). The Supplementary Mate-
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FIG. 1. (a) Raman spectra for α and γ crystals, showing
that the spectra are distinct. We show a needle-like α crystal
and non-needle-like γ crystal in the insets. (b) Image of one
our 96-well plates, at end of the crystallisation. This is for
the first of three runs at a salt concentration of 250 mg/ml.
Crystallisation has occurred in 94 wells, with 43 γ and 51 α.
Each well is circular and has an internal diameter of 6.8 mm.
rial has further details and sets of Raman spectra for
both polymorphs. The characteristic peaks of the β poly-
morph are not found. This allows us to use Raman spec-
troscopy to identify polymorphs. We can do this in situ
on crystals a millimetre or less in size, which allows us to
identify the polymorphs of the many hundreds of crys-
tals we needed to study to obtain robust statistics. See
Fig. 1(b) for an image of one of the 96-well plates we used
to study nucleation in a large number of samples in par-
allel. We are not the first to use Raman spectroscopy to
identify crystals. For example Sultana and Jensen5 used
it in microfluidic studies of seeded crystallistion, and Cui
et al.34 used it to study the results of contact-induced nu-
cleation. Diao and coworkers5 have previously identified
the polymorph of large numbers of single crystals in situ,
but their work relied on the different polymorphs of the
molecule ROY having very different visual appearances.
There have been many studies of the growth rate of
glycine crystals. Measured growth rates1–6,35 for glycine
vary from µm/h to mm/s, a dynamic range of 106; see
Fig.S1 of the Supplementary Material. Growth rates in-
crease rapidly with increasing supersaturation, and mea-
sured growth rates also depend on the experimental set
up. The α polymorph consistently grows faster than the
γ polymorph.
In the next section, we will introduce the statistical
tools needed to analyse the nucleation of competing poly-
morphs. We then have two results sections, one on nu-
cleation and one on crystal growth.
II. MATERIALS AND METHODS
Solutions of glycine and sodium chloride were made by
adding deionized water (Milli-Q, 18.2 MΩ cm) to solid
glycine (≥ 99% HPLC from Sigma, cat. no. G7126) and
sodium chloride (≥ 99.999% from Sigma, cat. no. 38979).
This solid glycine consisted of mainly the γ polymorph
but had a small amount of the α polymorph. We fully
dissolved the glycine during preparation of the solution.
The solution was heated to 70 ◦C in a sealed vial and
stirred at 1200 rpm for 1 h using a hot plate and magnetic
stirrer bar. At all NaCl concentrations, the concentration
of the glycine solution was fixed at 320 mg of glycine per
ml of water. Solutions were held in the pipette for a time
tH = 15 s before distributing into the wells.
A. Crystallisation experiments
Each experiment used a new microplate (Nunclon
Delta Surface) with 96 wells (arranged as 8 rows of 12
wells, see Fig. 1(b)). Each well initially contained 100 µl
of tridecane (≥ 99% from Sigma-Aldrich). Then, 100 µl
of the heated glycine solution was transferred simultane-
ously into each well in successive rows of wells using a
12-channel multipipette (Scipette). The glycine solution
was deposited on top of the tridecane after which it would
immediately sink below the oil because of its higher den-
sity. The plate and samples cooled to room temperature
within the first hour of the experiment. The experiments
were carried out in a temperature controlled room, with
a setpoint at 21◦C. There are slight variations in tem-
perature during the experiment, as was discussed in our
earlier work10, where there are further details of our ex-
perimental setup.
B. Determination of nucleation times
Images of samples were recorded with a Logitech HD
Pro Webcam C920 placed underneath the microplate, as
in our earlier work10. An example image is shown in
Fig. 1(b). Images of the microplate were recorded at a
resolution of 1080× 1920 pixels. An image was recorded
every 10 min for the first 3 h, then every 30 min for the
following 6 h, and then at every hour for the remainder
of the experiment. The images were then analysed by eye
to determine the time at which each sample crystallized.
C. Crystal sizes and growth rates
We define the size of a crystal as being the largest dis-
tance across a crystal, as illustrated in Fig. S2 of our
earlier work10. The wells are 6.8 ± 0.2 mm in diam-
eter, which is 90 pixels in our images, so one pixel is
approximately 0.076 mm across. The smallest crystal we
3observed was two pixels diagonally across. This corre-
sponds to a center-to-center distance of
√
2× 0.076 =
0.11 mm. This as an approximation of the smallest size
at which a crystal can be detected.
We define needle-like crystals as follows. The as-
pect ratio of crystals can change over time, and initially
needle-like crystals may become less needle-like as time
progresses. Here, we define needle-like crystals, as crys-
tals that have an aspect ratio above 5:1 for at least the
first five hours after nucleation.
D. Experiments heated after 18 h
For one set of experiments, we heated the filled mi-
croplate 18 hours into each experiment. The microplates
were heated in a Sanyo Mov-112F oven. The tempera-
ture within the oven was measured to be 30.4 ◦C, which
remained constant to within 0.1◦C. The samples were
kept at this temperature in the oven for 48 h. The mass
of the samples was measured before and after experi-
ments to check for evaporation of the water (tridecane is
much less volatile). The microplate was found to be 0.1
g lighter after the samples had been in the oven for 48 h.
This corresponds to evaporation of 1% of the total mass
of glycine solution.
E. Raman spectroscopy of glycine
To identify the polymorph of a crystal, we used an
NTEGRA Raman microscope (NTEGRA, NT-MDT)
equipped with a 20x objective lens, and a 473 nm laser.
The laser exposure time was 20 s for all samples. The
crystals remained in solution within the wells while the
Raman spectroscopy was carried out. If a well contained
more than one crystal, we obtained spectra from two
crystals in the well. The two spectra were always iden-
tified as the same polymorph. Raman spectra, together
with the XRD patterns we used to validate our use of
Raman spectra to identify polymorphs, are in the Sup-
plementary Material.
III. STATISTICS OF THE NUCLEATION OF
COMPETING POLYMORPHS
Our droplets of supersaturated solution are sufficiently
small that in each droplet we only ever observe the nucle-
ation of one polymorph, either α or γ. In other words nu-
cleation of the two competing polymorphs are mutually
exclusive events. Thus each droplet contributes a time
and a polymorph, e.g., nucleation after 2 h, of the α poly-
morph. Our data is therefore of exactly the form studied
over many years by medical statisticians who study com-
peting causes of mortality14–17. Their data is also a time
and a label, e.g., death 32 weeks after surgery, due to
heart disease, death after 22 weeks, due to cancer, etc.
Medical statisticians have developed powerful tech-
niques and best practices for analysing data of this form.
We propose that the study of competing polymorphs will
benefit greatly from using the methods developed in med-
ical statistics. The study of competing irreversible pro-
cesses is called survival data analysis20,42,43. Survival
here means the survival either of a patient, or here of
the solution state, i.e., survival until death or nucleation.
Here we introduce the standard way of modelling data of
our form.
Survival data in the presence of competing processes
are typically plotted as what are called cumulative inci-
dence functions (CIFs)17,20. We record two CIFs, one for
the α polymorph, Iα, and one for the γ polymorph, Iγ .
The CIF Ii(t) is defined as the probability that nucleation
has occurred at or before time t, and that polymorph i
has nucleated. The survival probability P (t) is the prob-
ability that nucleation has not occurred at or before time
t, so P (t) = 1− Iα(t)− Iγ(t).
The effective nucleation rates for the two polymorphs,
hα(t) and hγ(t), are examples of a type of function called
cause-specific hazard functions (CSHs)17,20. The CSH for
the nucleation of polymorph i, hi, is
17,19
hi(t) =
1
P (t)
dIi(t)
dt
i = α, γ (1)
In words: the effective nucleation rate of a polymorph is
the time derivative of the polymorph’s CIF, divided by
the fraction of wells remaining uncrystallised, P (t).
Both CIFs and CSHs are observables: CIFs are what
we measure, and CSHs are time derivatives of the CIFs.
It is important to note that although we refer to hα as
an effective nucleation rate for the α polymorph, hα also
depends on γ nucleation. We only observe one polymorph
in a well, so once a γ crystal has formed in a well, α
nucleation will not occur. The two competing processes
are entangled, we cannot separate them out, and so care
is needed in interpreting hα and Iα. This problem is
discussed by Geskus20 and by Beyersmann et al.17.
Models that include only observables
As CSHs are observables, if we directly model these
then we have a model that uses only experimentally ob-
servable functions. We model the CSHs (the effective
nucleation rates) as power laws, with exponents βi and
characteristic timescales τi. These CSHs have the form of
the hazard function of the widely used4 Weibull function:
hi(t) = βi
(
tβi−1/τβii
)
i = α, γ (2)
This model includes the time-independent nucleation
rate as a special case (βi = 1).
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FIG. 2. Plot of CIFs at the salt concentrations of 250 mg/ml.
The points are our data: Iα (blue), Iγ (green) and Iα + Iγ
(red), respectively. Purple curves are fits to a model in which
the values of tnuc,α and tnuc,γ for a single well are uncor-
related, and are taken from a Weibull distribution. This is
equivalent to a fit to Weibull CSHs. The yellow curves are
from a fit of a model in which the values of tnuc,α and tnuc,γ
for a single well are correlated with a Spearman’s rank coef-
ficient of 0.95.
A. Models with latent nucleation times
Another approach to modelling our competing nucle-
ation processes is to associate two nucleation times with
every droplet14–17,20: a nucleation time for the α poly-
morph, tnuc,α, and a nucleation time for the γ poly-
morph, tnuc,γ . We only observe the shorter of these two
times. The first nucleation event preempts nucleation of
the other polymorph, and so we do not observe the longer
time. This longer time is then latent, i.e., hidden, and so
is not an experimental observable.
Models with latent nucleation times are natural choices
for studying possible correlations between the competing
processes, and hence for making predictions of what we
would observe if we could somehow prevent one poly-
morph nucleating. Correlations would arise if both poly-
morphs are nucleating on the same impurity, or if the
less stable polymorph forms as a transient intermediate
to the formation of a more stable polymorph.
IV. RESULTS FOR THE COMPETING NUCLEATION
OF GLYCINE’S POLYMORPHS
A. Time dependence of the nucleation rates
In Fig. 2, we have plotted the CIFs for experiments
at a salt concentration of 250 mg/ml. The α and γ nu-
cleation rates have opposite time dependencies: γ nucle-
ation starts fast, Iγ has an initial steep rise, but then
it slows, while α nucleation starts slow but accelerates.
Toward the end of the experiment, Iα almost catches up
with Iγ .
To quantify the variation in the nucleation rates with
time, we have fitted models with Weibull-type CSHs
(equation (2)) to the experimental CIF curves. The best-
fit parameter values are plotted in Fig. 3, the numbers
are in Table S2. A value of β < 1 gives an effective nu-
cleation rate that slows down as time passes, while β > 1
means that the rate accelerates with time. At 250 mg/ml
salt, βγ = 0.48 and βα = 1.41, which confirms that γ nu-
cleation slows with time while α nucleation accelerates.
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FIG. 3. The Weibull exponents βi (a), and τi (b) for fits to
the nucleation rates of both polymorphs, as functions of the
concentration of NaCl. In (a) we have shaded in yellow the
region where the nucleation rate increases with time, and in
blue the region where it decreases.
The nucleation rate for the α polymorph only accel-
erates with time at high salt. At low salt the effective
nucleation rate for α, the CSH hα, actually decreases
with time; the best-fit values of βα in Fig. 3 are less than
one except at the highest salt concentration. Increasing
the salt concentration not only slows down the timescale
for α nucleation, τα, it also qualitatively changes the ki-
netics of nucleation, from initially fast nucleation that
slows, to initially slow nucleation that accelerates. Plots
of CIFs for five salt concentations are shown in Fig. S7
of the Supplementary Material. Increasing the salt con-
centration dramatically decreases the apparent timescale
for γ nucleation, as shown in Fig. 3(b). At high salt
concentrations a larger fraction of the crystals are of γ
polymorph (Fig. S8).
We note that our lowest salt concentrations of 60
mg/ml significantly accelerates nucleation with respect to
no added salt, which is why we work at a glycine concen-
tration of 320 mg/ml, lower than the 333 mg/ml where
we obtained most of our data in our earlier work10. But
then at higher salt concentrations the rate slows down
again. The nucleation rate does not vary monotonically
with salt concentration.
The CIFs in Fig. 2 are obtained by adding together
three individual runs. The CIFs for individual runs are
shown in Fig. S9(e) in the Supplementary Information.
The shapes of the CIFs for individual runs are the same
as in Fig. 2, so our conclusions on the time dependencies
of α and γ nucleation are highly reproducible. There
is however significant run-to-run variability in the total
amount of nucleation we observe, and to a lesser extent in
the fractions of the polymorphs that form. This was also
found in earlier work10 and is common in crystal nucle-
5ation. For the three runs that make up the data in Fig. 2
the final fractions of the crystals that formed that were of
the γ polymorph that form are 47%, 40% and 72%, while
the final fraction of wells where crystallisation occurred
was 98%, 45% and 48%. Reproducibility is comparable
at other salt concentrations, see Supplementary Material.
B. We cannot determine if the nucleation of the α and γ
polymorphs is correlated
One obvious question about the nucleation of the com-
peting polymorphs is: Are α and γ nucleation correlated?
By correlated, we mean that if in an individual well the
α polymorph is likely to nucleate early, is the γ poly-
morph also likely to nucleate early? We expect that the
nucleation in our samples is heterogeneous, i.e., occur-
ring on impurities, and so if the same impurities tend to
induce nucleation of both polymorphs, we would expect
nucleation of the polymorphs to be correlated.
TABLE I. The best-fit values for fits of Fig. 2. Note that
the uncorrelated values refer to both the case of uncorrelated
latent nucleation times, and to the case of Weibull CSHs, the
two cases are mathematically equivalent. R2i , i = α, γ, is the
R2 value for comparison of the fit Ii to the data.
βα βγ τα (h) τγ (h) R
2
α R
2
γ
Uncorrelated 1.41 0.48 244 610 0.99 0.99
Correlated 0.92 0.60 164 260 0.98 0.99
Unfortunately, Tsiatis14 has rigorously proved that
from data of our form (nucleation time plus polymorph
for each well), we cannot determine if the competing pro-
cesses are independent of each other, or are correlated.
We have illustrated this in Fig. 2, where there are fits
of our data using models with and without correlations.
The two fits are essentially as good as each other; the R2
values in Table I, are almost identical. The model with
correlations was based on latent nucleation times; details
are in the Supplementary Information.
We can see in Table I that when the hazard functions
are correlated, the best fit β and τ parameters are signif-
icantly changed. Both βα and βγ are now less than one,
so if there are strong correlations, the data is consistent
with both nucleation rates decreasing with time. We do
not know the degree of correlation between α nucleation
and γ nucleation, and multiple β and τ parameters will
fit the data equally well, but with different correlations.
This means that with data of this type, we can say almost
nothing about what we would observe in the hypotheti-
cal cases where we could prevent nucleation of one poly-
morph, and just observe nucleation of the other14–17,20.
C. Polymorph composition vs time
At high salt, the two hazard functions hα and hγ have
opposite time dependencies, which implies that the poly-
0
0.2
0.4
0.6
0.8
1
0 24 48 72 96 120 144 168
Fr
ac
ti
o
n
 γ
t/ h
60 mg/ml
90 mg/ml
150 mg/ml
200 mg/ml
250 mg/ml
FIG. 4. Polymorph composition as a function of time. The
composition is the fraction of the wells where crystallisation
has occurred, that contain the γ polymorph. The lines start
at the point when a total of ten nucleation events have oc-
curred. Each curve is obtained from all runs at that salt
concentration.
morph composition varies with time. We have plotted the
polymorph composition as a function of time in Fig. 4.
We plot nγ(t)/[nα(t) +nγ(t)], where nα(t) and nγ(t) are
the number of wells containing α crystals and γ crystals
at time t, respectively.
If we consider the curve for 250 mg/ml NaCl, we see
that the fraction of γ starts at one (pure γ) and decreases
towards its final value of 0.56. This is consistent with our
Weibull fits that have exponents βα > βγ (see Fig. 3),
and so give a hα(t)/hγ(t) that is an increasing function
of time. We have many fewer γ nucleation events at
other salt concentrations, so our conclusions are less re-
liable there, but it seems likely that at all salt concen-
trations the fraction of the γ polymorph decreases with
time. We are not the first to observe a polymorph pu-
rity that changes with the time, Diao et al.5 found this
behaviour for the molecule ROY (see their Figure 8).
D. Time-dependent supersaturation increases polymorph
purity
When producing crystals, the aim is often to obtain a
particular polymorph with high purity. We observed that
at a salt concentration of 250 mg/ml, γ glycine nucleation
dominated at early times, but then the α nucleation rate
increased. This suggests that stopping nucleation early
in the experiment will increase γ-glycine purity. To test
this hypothesis we performed additional experiments at
250 mg/ml NaCl. In these experiments we reduced the
supersaturation after 18 hours, by increasing the temper-
ature from room temperature (21 ◦C) to 30.4 ◦C. This
had the effect of almost completely halting nucleation af-
ter 18 hours; in two runs only one crystal nucleated after
18 hours.
The final fraction of crystals that are in the γ poly-
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FIG. 5. Plot of the maxium distance across a crystal, as a
function of time since it nucleated. Data is shown for ten α
and ten γ crystals. These are seven α needle crystals plus
three α non-needle crystals, and one γ needle plus nine γ
non-needles. For each crystal t = 0 is defined as the time of
the first image in which there is a visible crystal. The salt
concentration is 250 mg/ml.
morph increases from 0.56±0.04 to 0.94±0.02. Here, the
first number is the final fraction of γ crystals at the end
(168 h) of three isothermal runs, and the second number
is the fraction of γ crystals after 18 h, of all five runs.
The CIFs for these experiments are in Fig. S10.
V. RESULTS FOR THE GROWTH RATES AND
CRYSTAL HABITS OF GLYCINE CRYSTALS
Having considered nucleation, we will now turn to con-
sider crystal growth. We will present results that show
that nucleation and growth are linked. We have plotted
the sizes of 10 α and 10 γ crystals, as a function of time,
in Fig. 5.
Note that we estimate the size of a crystal, by using
the maximum length across the crystal; see the Materials
and Methods section, and our earlier work10 for details
of how we measure size. Some crystals grow as needle-
like shapes, while others have more compact habits. We
show example crystals with needle and non-needle habits
in Fig. 6.
Three things are clear from Fig. 5: i) The growth rates
of the linear dimension of both polymorphs vary between
one crystal and another. ii) Much of this variability is
related to crystal habit. Needle-like crystals have much
faster growth rates along their long axis than do non-
needle-like crystals. iii) Growth of the α polymorph is
generally faster than the γ polymorph (in agreement with
other studies2). Note that growth of the needles perpen-
dicular to their long axis is quite slow, approximately
comparable to the growth rate of non-needle-like crys-
tals. Therefore, although one axis of the needles grows
very rapidly, the growth of the volume of these crystals
may not be faster than the growth of the volume of the
non-needle-like crystals.
(a) (b)
FIG. 6. Here we show some typical crystal habits. (a) is a
needle-like α crystal, observed less than an hour after nucle-
ation. (b) is a non needle-like α crystal observed 5 h after
nucleation. The scale bar in (a) applies to both images.
We do not know why the growth rate of crystals grow-
ing under identical conditions is so variable. Crystal
growth often relies on defects46, and so it may be due
to different crystals acquiring different defects as they
grow. But whatever the cause, this variability has conse-
quences. For example, any crystallisation model that as-
sumes a single well-defined growth rate at a given super-
saturation is clearly very far from the truth for glycine.
0
0.1
0.2
0.3
0.4
0.5
0.6
0 25 50 75 100 125 150
Fr
ac
ti
o
n
 n
ee
d
le
-l
ik
e
Number of wells containing α glycine
60 mg/ml
90 mg/ml
150 mg/ml
200 mg/ml
250 mg/ml
FIG. 7. For the α polymorph, we plot the fraction of crystals
with a needle-like habit, as a function of the total number of
wells that contain α crystals.
A. Nucleation time and crystal habit
Next we look at whether the habit of a crystal depends
on the time at which it nucleates. In Fig. 7 we plot the
fraction of crystals of the α polymorph that are needle-
like, as a function of the total number of wells with α
crystals. The x-axis is effectively a time axis, as the
number crystallised increases with time, but using the
number crystallised as the x-axis allows easier compari-
son between different salt concentrations.
At early times almost all crystals have the non-needle-
like habit. However, at later times most crystals that
nucleate are needles, so the fraction of needle-like crystals
increases rapidly. There is a very strong dependence of
crystal habit on nucleation time. This is due to these
7late-nucleating crystals having much faster growth along
one axis (only). For example at 60 mg/ml, for the first
70 α nucleation events, six are needle-like crystals, but
for the following 70 nucleation events, 51 are needle-like.
For γ crystals at high salt concentrations, we see the
same trend, see Fig. S14, but as we have few needle-like
γ crystals, our statistics are poorer.
We were surprised when we found that typical late-
nucleating crystals have a very different growth rate
along one axis than typical early-nucleating crystals. We
analysed the Raman spectra for needles and non-needles,
see Supplementary Material. Although there is crystal-
to-crystal variability in the Raman spectra, there is no
sign of any systematic difference between the set of the
spectra of needles, and the set of spectra of the non-
needles. So via Raman spectroscopy we separated our
crystals into two sets: one set with spectra chracteristic
of the α polymorph, and one with spectra characteris-
tic of the γ polymorph9. Both sets of crystals contain
needles and non-needle-like crystals. Our XRD patterns
(Fig. S3(a) and Fig. S4) confirm this finding.
Finally, note that in these XRD patterns we only ever
observe peaks characteristic of the α and γ polymorphs;
characteristic peaks for β are absent (Fig. S4). In ad-
dition, the β polymorph is not typical for crystallisation
from aqueous solutions, and indeed under these condi-
tions is expected to be unstable with respect to conver-
sion to the α form47. We do not observe visible changes in
habit that might suggest polymorph-to-polymorph con-
version.
We do not know what causes the growth and habit dif-
ference between early- and late-nucleating crystals. How-
ever, if it is due to differences in defects that control crys-
tal growth, then this suggests that nucleation may involve
more than one step, and that at least one of these rate
limiting steps involves nucleation of a growth defect. It is
possible that our initially slow nucleation of the α poly-
morph at high salt concentration is associated with slow
or multistep defect nucleation, which is needed before
that polymorph can grow.
VI. CONCLUSIONS
We have studied the competing nucleation of two crys-
tal polymorphs of glycine, using Raman spectroscopy to
identify the polymorph of individual crystals. We found
that at high salt, the nucleation behaviour of the com-
peting polymorphs is analogous to the competition of
the tortoise and the hare in Aesop’s story. In the story,
at first the hare runs faster than the tortoise, but then
the hare goes to sleep, allowing the tortoise to overtake
it. Like the hare, γ nucleation is initially fast but then
slows, while α nucleation accelerates during the experi-
ment, and so the rate of α nucleation overtakes that of γ
nucleation.
This observation can be exploited. Drawing on this ob-
servation, we predicted that reducing the supersaturation
after 18 h would increase the purity of the γ polymorph.
It did, the fraction of the α impurity was reduced from
44% to 4%. Thus, the complex time dependence of com-
peting polymorphs can be exploited to greatly increase
the purity of a polymorph.
By using a result from medical statistics14, we were
able to prove that with our data it is impossible to dis-
entangle the nucleation of α and γ polymorphs14–17,20.
These two processes may or may not be strongly corre-
lated — we simply do not know. This means that care
must be taken when interpreting results on competing
polymorphs. For example, if we alter an experimental
parameter, such as salt concentration, pH, etc, and ob-
serve more of one polymorph, that does not allow us to
infer that the nucleation rate of that polymorph has in-
creased, the rate of the competing polymorph may have
decreased16. Work by medical statisticians over the last
40 years has found that interpretation of data of our form
is subtle, and so we will need to learn from their work, in
order to correctly understand the competition between
polymorphs.
A possible way around this problem is to use the ex-
perimental approach of Laval et al.11, who cycled their
system, to repeatedly induce crystallisation and disso-
lution of crystals, in a set of droplets produced by mi-
crofluidics. They did not consider polymorphism, but if
their approach can be applied to a system with compet-
ing polymorphs, then the two competing processes could
then be disentangled.
All our results are obtained from system volumes of
0.1 ml, and in common with most earlier work, we do not
know how varying the volume will change what is seen.
However, we do note that our droplets are large enough
that we often observe two or more crystals, and that in
all cases studied (via Raman) all the crystals in the same
droplet are of the same polymorph. This strongly sug-
gests that the nucleation events that produce multiple
crystals in a single well are not independent. The sec-
ond, third, etc, crystals may be forming via secondary
nucleation48,49, i.e., arising due to the already-existing
crystal.
In addition to nucleation, we also studied crystal
growth. For both polymorphs we observed fast grow-
ing needle-like crystals, and much slower growing non-
needle-like crystals. Nucleation time, crystal habit and
growth rate are all correlated. Crystals that nucleate at
late times tend to have needle-like habits, and to grow
rapidly. This appearance of the fastest growing crystals
at late times is the opposite to what we would expect.
Further work will be needed to understand the mecha-
nism that underlies this interesting observation.
SUPPLEMENTARY MATERIAL
The Supplementary Material contains: (I) Literature
data on the growth rates of glycine crystals. (II) The sol-
ubility of glycine in water, as a function of temperature.
8(III) Raman spectra and XRD patterns of our crystals, as
well as reference XRD patterns of all three polymorphs,
for comparison. (IV) Details of the statistical techniques
we borrow from the field of medical statistics, to model
our data. (V) Additional experimental results for nucle-
ation. (VI) Additional experimental results for growth.
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9Supplementary Material for: Controlling the crystal polymorph by exploiting the
time dependence of nucleation rates
This supplementary material has six sections:
(I) We discuss literature values of glycine crystal growth rates in the main text. In this section we plot the rates
as a function of supersaturation and we give details of the experimental conditions in these studies.
(II) This contains plots of the solubility of glycine in water, as a function of temperature.
(III) This section contains Raman spectra of the α and γ polymorphs of glycine. We also show the X-ray diffraction
(XRD) results that validate Raman spectroscopy’s ability to distinguish between the two polymorphs of glycine.
(IV) Background to the statistics needed to understand the nucleation of competing polymorphs, and details of the
models we used.
(V) Additional experimental results for nucleation.
(VI) Additional experimental results for growth.
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Figure S1. Glycine crystal growth rates, are plotted as a function of supersaturation. This is data from five earlier studies:
[Li] (Li et al.)1, [Han-A] (Han et al.)2, [Han-B] (Han et al.)3, [Dow] (Dowling et al.)4 and [Sul] (Sultana et al.)5. These growth
rates have been obtained from graphs, so are approximate. Colour coding is as follows, α b-axis, α c-axis, γ b-axis and γ c-axis
are pink, green, gold and dark blue respectively. [Sul] used an anti-solvent, other studies are purely aqueous.
I. LITERATURE STUDIES OF THE GROWTH OF GLYCINE CRYSTALS
In the main text we discussed literature values for the growth rates of glycine crystals. These rates are plotted
in Figure S1. There was one growth rate6, of ≈ 80, 000 µm/min, which was too large to fit on our graph. The
experimental details for these experiments are summarised in Table S1.
Crystal growth rates appear to be very sensitive to crystal and solution properties, such as crystal size and solvent.
The growth rates of α glycine measured by Sultana et al. are lower than those measured by Han et al. and Dowling et
10
Table S1. The experimental details of a number of studies on glycine growth. The growth rates from these studies are shown
in Figure S1.
Authors Supersaturation Experimental set-up
range
Toldy et al.6 3.5− 6.5 Crystals nucleate in supersaturated droplets within an emulsion at
84◦C. Crystals sizes are of the order of tens of µm.
Dowling et al.4 1.3− 1.45
Individual crystal seeds are placed in supersaturated solution, and ob-
served under a microscope at 20◦C. Crystal sizes are of the order of
mm. Solubility cs is given as 212 g/l.
Han et al.4 1.15− 1.6
Individual crystal seeds are placed in supersaturated solution and ob-
served under a microscope at 23◦C. Crystal sizes are of the order of
mm. Solubility cs is given as 226 g/l.
Sultana et al.5 1.08− 1.75
Supersaturated solutions containing crystal seeds flow through a PDMS
(poly-dimethylsiloxane) microfluidic device. Solutions are supersatu-
rated using the anti-solvent methanol. Crystal sizes are of the order
tens of µm
Li et al.1 1.01− 1.08
Crystal seeds are placed in a glass cell at 23◦C while supersaturated
solution flows through the cell, seed sizes are of the order of hundreds
of µm
Han et al.3 1.5 Set-up is the same as in Dowling et al.4
al. In the work of Sultana et al., the glycine solution is supersaturated by the addition of the anti-solvent methanol,
while in the experiments of Han et al. and Dowling et al. only water and glycine are present. Also, both Dowling
and Han work with crystals with sizes of the order of mm, while Sultana et al. work with crystals of sizes of the order
tens of µm. It may be that the presence of methanol is affecting the growth of crystals in the experiments of Sultana
et al, and the crystal growth rate may also be changing with crystal size.
II. GLYCINE SOLUBILITY
For glycine in water the solubility varies as shown in Figure S2. We can see that glycine’s solubility is very sensitive
to temperature. This is beneficial in that it allows us to easily create highly supersaturated solutions (by cooling),
but problematic in that to perform an experiment at constant supersaturation, temperature must be controlled very
precisely. The curve in Figure S2(a), is used for our supersaturation calculations. We include solubility data from
several sources in Figure S2(b) to show that values for glycine solubility in the literature can vary significantly between
studies.
III. VALIDATION OF RAMAN SPECTRA FOR IDENTIFYING THE α AND γ POLYMORPHS OF GLYCINE
The α and γ crystals have distinct Raman spectra, which can be identified by a set of distinctive peaks9. Examples
of spectra from each polymorph are given in Figure S3(b). Both polymorphs have a very intense peak at 886 cm−1.
There are clear differences between the two spectra in the region 100-200 cm−1 where the peaks can be attributed to
intermolecular vibrations9. The α polymorph has several small peaks (relative to the 886 cm−1 peak) at 118 cm−1,
164 cm−1, 171 cm−1 and 203 cm−1, which the γ polymorph does not have. The 203 cm−1 peak is often of low intensity
and the peaks at 164 cm−1 and 171 cm−1 are often merged. Spectra where these peaks are more clearly visible can
be seen in Figure S3(c) and (d). The γ polymorph has a very intense peak (comparable in intensity to the 886 cm−1
peak) at 157 cm−1, which the α polymorph does not have. There are also differences between the polymorphs at ≈
500 cm−1. The α polymorph has two low intensity peaks at 492 cm−1 (NH3 torsional mode9) and 502 cm−1 (CO2
rocking mode9) while the γ polymorph has just one high intensity peak at 504 cm−1.
X-ray diffraction (XRD) was used as a test to confirm the results of our Raman spectroscopy analysis. A sample of
crystals was analysed with Raman spectroscopy (the two example spectra shown in Figure S3(b)). Immediately after
the Raman spectroscopy had been carried out, the crystals were removed from the microplate and separated into two
groups: Those that had been identified as α glycine and those that had been identified as γ glycine. The two samples
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Figure S2. Solubility in water of the α and γ polymorphs of glycine as a function of temperature. (a) Data from Yang et al7.
We have fit a second order polynomial (black curve), so that the solubility can be approximated between data points. This fit
is solubility (g/kg) = 0.0301T 2 + 2.96T + 109, with T in
◦
C. (b) Comparison of γ glycine solubility from several sources: Yang
et al.7, Dowling et al.4, Han et al.3 and Yi et al.8.
were then prepared for XRD using the same procedure as described in earlier work10. The crystals were ground up
into a fine powder before analysis. Powder XRD was carried out using a PANalytical XPert Pro diffractometer across
a 2θ range of 10 − 70◦ using Cu Kα radiation. The resulting XRD patterns can be seen in Figure S3. In Figure S3
we have identified peaks as belonging to either the α or γ polymorphs using the standard JCPDS XRD patterns of
these polymorphs. The α polymorph pattern is JCPDS number 00-032-1702, and the γ polymorph is JCPDS number
00-006-0230.
As expected, the set of crystals which we identified as α with Raman spectroscopy are found to show only α glycine
peaks with powder XRD. The Raman spectra and XRD were also in agreement for the set of γ crystals. We never
observed the third polymorph of glycine, β glycine, in our XRD patterns. The β polymorph can form needle-like
crystals11, resembling those we do see, but the XRD patterns rule out significant amounts of the β polymorph, at the
point at the end of the experiment when XRD patterns are taken. In Figure S4 we have plotted our XRD patterns
together with reference α, γ and β patterns. Note that this range of 2θ includes the strongest peak of the β polymorph
(at 2θ = 18.1◦) which is absent in both our sets of diffractograms.
During the course of our experiments, we do not observe habit changes of our crystals. This suggests that once
formed, our crystals do not transform into another polymorph. However, both Raman and XRD analyses are made
at the end of our runs, which is days after many of the crystals formed. Thus, although it seems unlikely, we cannot
rule out a polymorph-to-polymorph transformation during our experiment that does not affect habit.
A. Raman spectra for needle-like and non-needle-like crystals
We were surprised by our observation that both polymorphs formed two very different crystal habits, in each case
a needle-like habit and a much more compact habit. So we looked carefully at the Raman spectra we obtained from
these crystals. Raman spectra for needle-like and non-needle crystals are shown in Figure S5 for the α polymorph
and in Figure S6 for the γ polymorph. In Figure S5(a) we see Raman spectra from 50 needle and non-needle-like
crystals, of the α polymorph. Figure S5(c) is a scatter plot of estimates of the height of the peak nominally located
at 118 cm−1, versus its position, and the height of the combined 164 and 171 cm−1 peaks, versus their location. The
peak heights and positions are obtained by fitting the sum of two Gaussians plus a constant background term to the
spectra over the range 100 to 200 cm−1. Note that the Raman spectrum of the β polymorph is distinct from that
of the α and γ polymorphs12,13. The Raman spectrum of the β is flat betweeen approximately 120 and 200 cm−1,
whereas we see peaks in that range, in both Figures S5 and S6.
Note that there is clearly significant variability in the peak height, but that almost all estimates of the peak position
are within a narrow range. The distributions of the peak heights and positions of the needle and non-needle crystals
are indistinguishable. As far as the Raman spectra are concerned, the needle-like and non-needle-like both have the
characteristic α polymorph peaks at the same position, and in both cases with variable intensity. Whatever the cause
of the fast growth along one axis of the needles, it is not apparent in the Raman spectra. This would be consistent
with the difference in growth rates being due to different defects, as these defects would be unlikely to show up in the
Raman spectra.
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Figure S3. (a) XRD patterns of two powdered samples, one of α glycine and one of γ glycine as identified with Raman
spectroscopy. The glycine identified as α via Raman spectroscopy is shown in blue and glycine identified as γ is shown in
green. The circles represent known α XRD peaks while the triangles represent known γ XRD peaks. (b)(i) Raman spectra for
a typical α glycine crystal and a typical γ glycine crystal. The spectra are normalised to the intensity of their highest peak at
886 cm−1 (b)(ii) The spectra of (b)(i) in the region 100 - 250 cm −1.(b)(ii) The spectra of (b)(i) in the region 450 - 550 cm
−1. (c) and (d) Two additional α glycine spectra where the characteristic peaks at 164 cm−1, 171 cm−1 and 203 cm−1 (which
cannot be easily seen in (b)(ii)) can be more clearly seen.
The corresponding data for the γ polymorph needle-like crystals and non-needle-like crystals are in Figure S6. As
with the α polymorph, there is no apparent difference between the set of needle spectra and the set of non-needle
Raman spectra.
IV. STATISTICS AND MODELS FOR THE NUCLEATION OF COMPETING POLYMORPHS
As we only observe one polymorph or the other in a single well, not both, nucleation of the two polymorphs are
mutually exclusive events in our system. Thus our data on the kinetics of nucleation of single crystals of competing
polymorphs consist of the pair of observations, (tnuc, i = α, γ), for each well where crystallisation occurred. We want
to analyse this quantitative data to build the most robust model with the greatest predictive power.
The statistics of the nucleation of competing polymorphs is subtle, but fortunately, analogous data sets occur in
13
16 18 20 22 24 26 28 30 32
2 /degrees
0.0
0.2
0.4
0.6
0.8
1.0
No
rm
al
ise
d 
co
un
ts
 ref
 ref
 ref
Figure S4. Experimental XRD patterns of two powdered samples, one of α glycine (blue dotted curve) and one of γ glycine
(green dotted curve), as identified with Raman spectroscopy. The reference peak positions for all three polymorphs are shown
as solid vertical lines. Our PANalytical XPert Pro diffractometer uses JCPDS reference files, numbers 00-032-1702 (α), 00-002-
0171 (β) and 00-006-0230 (γ). We show a 2θ range where there are three strong β peaks that are all well separated from any
α or γ peak. None of the experimentally observed peaks match the β reference file. All five patterns are normalised such that
the highest peak has a height of one.
a number of other fields, in particular in medical statistics14–18. Typically in mortality studies, there are competing
illnesses or causes of death17,19,20. An example might be a study of, say, 100 patients at risk of dying of cancer or of
heart disease, where date and cause of death are recorded. As the two causes of death, like our competing polymorphs,
are mutually exclusive, the data is also of the form of a pair of observations: a time, and one of a number of competing
outcomes.
A. Models that include only observables
Our observables are the Ii, together with their derivatives hi, and P = 1− Iα− Iγ . We can construct models using
only these functions. We can create a model by specifying the two cause specific hazard (CSH) functions.
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Figure S5. (a) Raman spectra for 24 non-needle like (solid curves) and 26 needle-like (dashed curves) crystals, all of which we
identified as the α polymorph from its Raman spectrum. All crystals were obtained from run number one at a salt concentration
of 250 mg/ml. In two cases (green and orange dashed curves) there are anomalous spikes at single values in the data, which
may be due to energetic events (cosmic rays) in the detector. (b) Four each of the non-needle (solid curves) and needle spectra
(dashed curves) of (a), plotted in the range we use for fitting. (c) Plot of peak height versus peak position, obtained by a fit of
two Gaussians plus a constant background to the part of the Raman spectra in (a) between wavenumbers 100 and 200 cm−1.
We use two Gaussians as for α we expect9 one peak at around 118 cm−1, plus two peaks at 164 and 171 cm−1, where these
two peaks are merged into one in the spectra of most crystals. Note that in a few instances, a peak is very weak, fitting fails,
and an anomalous point, e.g., slightly negative height, is produced.
1. Fitting procedure for models that include only observables
The model we fit is defined by the definitions of Ii and of P :
dIi(t)
dt
= P (t)hi(t) i = α, γ (3)
P (t) = 1− Iα(t)− Iγ(t) (4)
with two boundary conditions Ii(t = 0) = 0. We can obtain an equation for dP/dt and integrate it, to obtain
P (t) = exp
[
−
∫ t
0
dt′ (hα(t′) + hγ(t′))
]
(5)
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Figure S6. (a) Raman spectra for 37 non-needle like (solid curves) and 7 needle-like (dashed curves) crystals, all of which we
identified as the γ polymorph from their Raman spectra. All crystals were obtained from run number one at a salt concentration
of 250 mg/ml. In three cases (blue dashed curve, magenta and red solid curves) there are anomalous spikes at single values
in the data, which may be due to energetic events (possibly cosmic rays) in the detector. (b) Four each of the non-needle
(solid curves) and needle (dashed curves) spectra of (a), plotted in the range we use for fitting. (c) Plot of peak height versus
peak position, obtained by a fit of a Gaussian plus a constant background to the part of the Raman spectra in (a) between
wavenumbers 100 and 200 cm−1. We use one Gaussian as for γ we expect9 one peak at around 157 cm−1.
which when the hi are Weibull CSHs, becomes
P (t) = exp
[
− (t/τα)βα − (t/τγ)βγ
]
(6)
Equation (3) then becomes
dIi(t)
dt
= exp
[
− (t/τα)βα − (t/τγ)βγ
]
βi
(
tβi−1/τβii
)
i = α, γ (7)
For given values of the four (two τi and two βi) parameters, we integrate the coupled ordinary differential equations
for the Ii, Eq. (7), to get the two Ii(t) functions. To fit to data we simply vary the four parameters, and minimize
the sum of the squares of the difference between the modelled Ii(t) and observed Ii(t). This is done using a Python
program21.
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B. Models with latent nucleation times
Models can also be constructed that rely on latent nucleation times, i.e., on hypothetical nucleation times tnuc,α
and tnuc,γ for each well. As we only observe one polymorph for a well, for those wells where we observe nucleation
we only measure the shorter one of these two times, the other one is not observable. Thus in all cases one of these
times is hidden, hence the name latent time. See Beyersmann et al.17 and Geskus20 for discussion of the advantages
and disadvantages of models that rely on latent times. Tsiatis14, Peterson15, and Slud and Byar16 both discuss the
limits of what can be inferred about tnuc,α and tnuc,γ , from data of our type. In general, the two nucleation times for
a single well will be correlated, for example there may be a tendency that if one nucleation time is small in a well,
that the other polymorph’s nucleation time in the same well, is also small.
We can write the probability that no nucleation has occurred in a droplet at time t as
P (t) = Pr(tnuc,α > t, tnuc,γ > t) (8)
i.e., the probability that both tnuc,α and tnuc,γ are greater than t.
1. Model with independent latent nucleation times
If the two nucleation times are independent then Eq. (8) simplifies to
P (t) = Pr(tnuc,α > t)Pr(tnuc,γ > t) (9)
If the two independent latent nucleation times are both modelled by Weibulls, then for the probability density function
for tnuc,i, we have
p(tnuc,i) = βi
(
tβi−1/τβii
)
exp
[
− (t/τi)βi
]
i = α, γ (10)
and the cumulative probabilities are
Pr(tnuc,i) = exp
[
− (t/τi)βi
]
i = α, γ (11)
When the latent times are independent, the rate at which α is observed to nucleate is just p(tnuc,α) times the
probability that nucleation of the γ polymorph has not yet occurred, so we have for α nucleation
dIα(t)
dt
= βi
(
tβα−1/τβαα
)
exp
[
− (t/τα)βα
]
× exp
[
− (t/τγ)βγ
]
= exp
[
− (t/τα)βα − (t/τγ)βγ
]
βα
(
tβα−1/τβαα
)
(12)
plus an analogous equation for dIγ/dt.
These two equations are identical to Eq. (7). So our model in the previous section that modelled the observable
CSHs, via Weibulls (equation (3) of the main text), can be obtained starting with latent nucleation times, and
then assuming that they are both Weibull distributed, and are independent. Thus the fits of our model using only
observables, are also what we would obtain from a model of independent latent times. However, it should be noted
that14, although for every set of observables Ii there is a corresponding model with independent latent times, for the
same Ii there are an infinite number of models with differently correlated latent times that yields this same Ii.
2. Computational generation of models with independent latent nucleation times
As we just discussed, a model with independent nucleation times is the same as our model based on observables.
Nonetheless, we now briefly describe how to generate a model based on independent latent nucleation times compu-
tationally here. Then in the next sub-section we describe how we introduce correlations. To generate the model with
independent times, we simulate the behaviour of a large number samples, and determine the fraction of those samples
at time t, where nucleation has not occurred, N(t). When the number of samples is sufficiently large N(t) ≈ P (t).
For each well we need both a tnuc,α and tnuc,γ , we then select the shorter time to be the nucleation time of the well.
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For this model we need to generate two sets of variables, tnuc,α and tnuc,γ , such that both sets of variable are
Weibull distributed. We can do this by generating a set of uniform random variables for each polymorph, and putting
each random number through the inverse cumulative distribution function (CDF) of a Weibull distribution.
y = τi(− ln(1− u))
1
βi i = α, γ (13)
Where u is a uniform random variable such that 0 ≤ u < 1 and y is the output variable which is Weibull distributed.
In this way we can easily create two independent sets of Weibull distributed nucleation times. We can then vary the
β and τ values to fit our data.
3. Model with correlated latent nucleation times
We do not know if nucleation of the two polymorphs is correlated. So to understand the role of correlations, it is
useful to have a model with variable correlations between the nucleation times of the two polymorphs. To generate
the model, we start, as in the previous section, with two sets of Weibull distributed numbers for tnuc,α and tnuc,γ . In
this case however we want those two sets of numbers to be correlated such that for a well with a short α nucleation
time there is a high probability of a short γ nucleation time
We set about generating the correlated nucleation times as follows. We generate two correlated sets of numbers,
both Gaussian distributed. We then put each number into a Gaussian CDF which transforms them to uniformly
distributed numbers between zero and one. After that, we put the uniformly distributed numbers into an inverse
Weibull CDF, Eq. (13). At this point, we have two Weibull distributed sets of numbers that are correlated. By
generating a large number of nucleation time pairs, we obtain Iα and Iγ pairs where the α and γ nucleation processes
have the desired correlation. We used these generated distributions to fit our data, in Figure 2 of the main text.
4. Measuring correlation
We use Spearman’s rank coefficient22 to measure correlation in this model. We briefly explain how Spearman’s
rank coefficient works. For each sample we have two times: tnuc,α and tnuc,γ . We rank all the tnuc,α, for all samples
in order of increasing length. We do the same with the set of tnuc,γ . We then measure for each pair of times the
difference between the tnuc,α rank, rα and the tnuc,γ rank, rγ . For example, if for one sample the nucleation times are
tnuc,α and tnuc,γ , and if tnuc,α is the 6th longest nucleation time (rα = 6) and tnuc,γ is the 11th longest nucleation
time (rγ = 11), then the difference in ranks, rγ − rα is 5. Note that if tnuc,α and tnuc,γ are perfectly correlated all
their ranks will be the same.
We measure the difference in rank for each pair of variables. The sum of the square rank differences is the covariance
of rα and rγ . The formula we use to calculate Spearman’s rank correlation coefficient, Rs, is
Rs =
cov(rα, rγ)
σrασrγ
(14)
where σrα and σrγ are the standard deviations of all rα and rγ respectively and cov(rα, rγ) is the covariance of rα and
rγ . When data are strongly positively correlated Rs approaches 1, when data are uncorrelated Rs is close to zero and
when data are strongly negatively correlated Rs approaches -1. The Spearman’s rank correlation coefficient between
the two functions in the model used in the fit in Figure 2 of the main text, is 0.95, i.e, α and γ nucleation are strongly
correlated.
V. ADDITIONAL RESULTS ON NUCLEATION
A. CIF plots for the five salt concentrations between 60 and 250 mg/ml
In Figure S7, we have plotted the CIFs: Iα, Iγ and the sum Iα + Iγ , for five different salt concentrations. We do
not plot results for the experiments at 300 mg/ml NaCl because there is little nucleation at this salt concentration.
Note the change of time scale between Figure S7(b) and (c). The experimental timescale is longer at higher NaCl
concentrations because as salt is added, nucleation slows. The plots for 250 mg/ml are also shown in Figure 2 of the
main text. The fit parameters for the Weibull fits are in Table S2.
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Figure S7. Plots of CIFs for five salt concentrations: (a) 60 mg/ml, (b) 90 mg/ml, (c) 150 mg/ml, (d) 200 mg/ml, and (e) 250
mg/ml. The legend in (e) applies to all plots. The points are our data: Iα (blue), Iγ (green) and Iα + Iγ (red), respectively.
Purple curves are fits of models with Weibull CSHs to the data.
B. Increasing salt concentration favours the γ polymorph
We plot the final fraction of crystals that are in the γ polymorph, in Figure S8. This is for experiments were carried
out at NaCl concentrations cNaCl from 60 mg/ml to 300 mg/ml. At least two runs were carried out at each salt
concentration. We define a run as the set of nucleation times recorded from one 96-well microplate. On completing
each run, the fraction of wells containing each polymorph was determined.
In Figure S8, the variation of the final fraction of crystals in the γ polymorph, fγ , is modelled using a logistic
function. The fit is shown as a black curve in Figure S8. The logistic function is
fγ (cNaCl) =
1
1 + exp
[−(cNaCl − c1/2)/cSW ] (15)
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Table S2. Best-fit values for fits of models with Weibull CSHs to the CIFS for α and γ nucleation.
NaCl τα (h) βα τγ (h) βγ R
2
α R
2
γ
(mg/ml)
60 7.49 0.26 4.74× 105 0.28 1.00 1.00
90 57.2 0.49 5.84× 105 0.26 0.99 1.00
150 245 0.49 3.35× 104 0.40 0.99 1.00
200 1650 0.89 1250 0.97 1.00 1.00
250 244 1.41 610 0.48 0.99 0.99
R2i , i = α, γ, is the R
2 value for comparison of the fit Ii to the data.
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Figure S8. The final fraction of wells that contain the γ polymorph, fγ , plotted as a function of NaCl concentration. The dark
green circles are the overall fraction averaged over all runs at a single NaCl concentration. The smaller green diamonds are the
fractions in individual runs. The solid curve is a fit of a logistic function to fγ = nγ/[nα+nγ ], where nα and nγ are the number of
wells containing α crystals and γ crystals, respectively. The error bars shown have a total height of 2 [fγ(1− fγ)/(nα + nγ)]1/2,
where nα is the number of wells containing α crystals and nγ is the number of wells containing γ crystals.
and it has two parameters: c1/2 and cSW . As we can see in Figure S8, this functional form fits our data well. The
best-fit parameters are c1/2 = 215 mg/ml, and cSW = 100 mg/ml. The parameter, c1/2, is an estimate for the salt
concentration at which half the samples are α and half γ. There is broad region, a few hundred mg/ml, over which
we go from a region with very small, but non-zero, amounts of the γ, to a large majority of the crystals in the γ
polymorph. The cSW parameter can be used as an estimator of the width of this region. The data is in Table S3.
Table S3. Values of fγ at six NaCl concentrations.
NaCl (mg/ml) fγ nα nγ
60 0.04 143 6
90 0.10 109 12
150 0.14 102 17
200 0.54 21 25
250 0.56 80 103
300 0.89 1 8
fγ is the fraction of wells at the end of the experiment, where the the crystal(s) are of the γ polymorph. Also shown
are the total numbers of wells with α and with γ crystals, nα and nγ , respectively.
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Figure S9. CIFs for individual runs at NaCl concentrations: (a) 60 mg/ml, (b) 90 mg/ml, (c) 150 mg/ml, (d) 200 mg/ml and
(e) 250 mg/ml. The key in (e) applies to all 5 plots. There are 2 runs in (a) to (d), and 3 runs in (e). For each run we plot Iα
as closed blue symbols, and Iα + Iγ as open red/brown symbols. For example, in (a) for the first run no γ crystals form, so the
solid and open symbols are on top of each other as Iγ = 0, while for the second run a small number of γ crystals start to form
after a few hours, and so the pale blue closed and open red symbols move apart.
C. Rates of nucleation, and total amount of nucleation are not well reproducible, relative rates and fractions are
reproducible
The nucleation time cumulative incidence functions (CIFs) are plotted for each individual run in Figure S9. The
CIFs in Figure S7 were obtained by combining the data in these individual runs. The number of wells in which
nucleation occurs, varies from run to run, i.e., reproducibility of the amount of nucleation is poor. What is reproducible,
is the fraction of nucleation events of each polymorph. In Figure S9, γ nucleation corresponds to the difference between
the all-nucleation CIFs and the α nucleation CIFs for each run. We see at low NaCl concentrations nucleation is
dominated by the α polymorph and this phenomenon is reproducible between runs. Even when two runs have a
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significantly different amount of nucleation occurring, the relative amount of the nucleation of each polymorph is
similar. For example at 150 mg/ml NaCl, see Figure S9(c), one run (dark red) has about three times more nucleation
events than the other (light red). However, for both runs, about 15% of the total nucleation events give the γ
polymorph.
It should also be noted that the distribution of nucleation times is reproducibly different for the two polymorphs at
the high salt concentration of 250 mg/ml NaCl, see Figure S9. The γ nucleation time distribution initially has a very
fast relative nucleation rate which slows down over time in all of the runs, while the α nucleation time distribution
initially has a very slow relative nucleation rate which speeds up over time giving an ‘s-shaped’ curve. This is well
illustrated by the median nucleation times of the subpopulations of α nucleating wells and γ nucleating wells for each
run. The median α nucleation times for the three runs are 77 h, 102 h and 81 h, while median γ nucleation times
for those runs are 13.5 h, 14 h and 34 h respectively. We can therefore say, in addition to the fraction of nucleation
that corresponds to each polymorph being reproducible, the relative change in the effective nucleation rates of the
two polymorphs is also reproducible.
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Figure S10. Plots of the sum of the two CIF functions, Iα + Iγ , i.e., the fraction of wells where crystallisation has occurred, is
plotted as a function of time. This is at 250 mg/ml salt. (a) The red triangles are the average Iα + Iγ , for all three isothermal
runs, and the purple crosses are is the average of two runs that are at 21 ◦C for the first 18 h, after which the microplate is
maintained at 30.4 ◦C for the following 48 h. (b) Here we have plotted the individual runs of the systems that were averaged
to obtain the data in (a). This is two runs heated to 30
◦
C after 18 h (runs 4 and 5), and the isothermal individual runs (runs
1, 2 and 3).
D. Time-dependent supersaturation increases polymorph purity
In Figure S10(a), we have plotted the sum of the two CIFs, Iα+Iγ for both isothermal experiments, and experiments
where the temperature is increased from room temperature (close to 21 ◦C10) to 30.4 ◦C, after 18 hours. All runs
are at 250 mg/ml NaCl. Note that for the experiments warmed to 30.4 ◦C, nucleation is almost completely stopped.
In Figure S10(b), we show the individual runs that make up Figure S10(a). We can see the trends observed in the
individual runs are the same as we observe in the datasets where all runs under the same conditions are combined.
E. Individual purity vs times
We have looked at how polymorph composition varies over time. Here we show that the runs that make up the
datasets plotted in Figure 4 follow the same trends. The runs are plotted in Figure S11, and data is shown in Table
S4.
22
0
0.2
0.4
0.6
0.8
1
0 24 48 72 96 120 144 168
Fr
ac
ti
o
n
 γ
t/ h
60 mg/ml
90 mg/ml
150mg/ml
200 mg/ml
250 mg/ml
Figure S11. Polymorph composition as a function of time. The composition is the fraction of the wells where crystallisation
has occured, that contain the γ polymorph. The lines start at the point when five nucleation events have occurred. Each curve
is one run, and the colour indicates the salt concentration. Different runs at the same concentration are distinguished by being
solid, dashed and dotted.
Table S4. Results of individual runs, for the fraction of γ at early times, and at the end.
NaCl conc / mg/ml Fraction γ at n≥10 Final γ fraction n≥10 tn≥10 / h
60 0.0 0.0 10 0.16
60 0.083 0.086 12 0.33
90 0.30 0.10 10 1.16
90 0.15 0.099 13 1.0
150 0.45 0.13 11 2.5
150 0.18 0.17 11 11
200 0.50 0.50 10 34
200 0.40 0.63 10 106
250 1.0 0.47 10 2.66
250 1.0 0.60 10 10
250 1.0 0.72 11 11
The second column is the fraction of crystals in the γ polymorph, at a time, tn≥10, early in the experiment. tn≥10 is
the earliest observation time at which we have 10 or more nucleation events; the precise number of nucleation
events, n≥10, is in column four. The third column is the fraction of the γ polymorph at the end of the experiment.
VI. ADDITIONAL RESULTS ON GROWTH RATES AND CRYSTAL HABITS
A. The effect of growth rates on the error in nucleation time measurements
Our measurements for nucleation times are only accurate if the time for nucleation, i.e., for the crystal to cross the
nucleation barrier and start growing irreversibly, is much larger than the time taken for the crystal to grow from just
past the barrier, to a size large enough to be visible.
We have plotted the sizes of 10 α and 10 γ crystals, at 90 mg/ml NaCl in Figure S12. Data for 250 mg/ml NaCl
are in Figure 5 of the main text. Note that growth rates vary with salt concentration. The crystals grow faster at 90
mg/ml of salt than 250 mg/ml. We focus on the γ crystals for estimating nucleaction time errors as their growth is
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Figure S12. Plot of the size of a crystal, as a function of time. The NaCl concentrations is 90 mg/ml. Data is shown for 10 α
and 10 γ crystals. The sizes of α crystals are shown as light blue (needles) and black (non-needles) lines-and-points. The sizes
of γ crystals are shown as red (needles) and green (non-needles) lines-and-points. For each crystal t = 0 is defined as the time
of the first image in which there is a visible crystal.
slightly slower than that of the α crystals. Here the growth rate for the γ crystals is around 2 mm/h. This means the
error in our nucleation time measurements should be less than 10 minutes in most cases. This is a small error for all
but the very shortest nucleation times.
For a salt concentration of 250 mg/ml, we plotted the sizes of 10 α and 10 γ crystals, as a function of time, in
Figure 5 of the main text. Most but not all of the γ crystals are growing at rate of around 0.2 mm/h. This implies
that our measured nucleation times are on average just over 30 mins too long, i.e., we first see a γ crystal about 30
mins after it nucleated as a microscopic nucleus. A few α crystals are also growing at around 0.2 mm/h, but most are
initially growing of order 10 times faster. Our runs at 250 mg/ml salt are of 168 h duration, so except for nucleation
at early times, a 30 mins error is a relatively small error.
Table S5. Mean glycine sizes at initial detection and at two subsequent times, for both α and γ polymorphs.
NaCl conc / mg/ml Time / mins Size/ mm
mean Interquartile range
α γ α γ
90 0 1.6 ± 0.5 0.6 ± 0.1 3.2 0.69
20 2.5 ± 0.7 1.2 ± 0.3 4.0 1.5
300 4.3 ± 0.5 3.0 ± 0.2 3.0 0.56
250 0 0.5 ± 0.1 0.17 ± 0.02 0.74 0.11
20 0.9 ± 0.2 0.23 ± 0.01 1.2 0.025
300 1.8 ± 0.3 0.9 ± 0.1 2.3 0.23
We estimate the uncertainties of the mean values with error estimates that are the standard deviation of the
measured sizes, divided by the square root of the number of crystals measured (10 crystals of each polymorph at
each concentration). We measure the width of the distribution of sizes of the crystals via the interquartile range.
B. Variation in growth rates between crystals
In Table S5, we present crystal sizes at three times, from the same data set as used in Figure 5 and Figure S12. In
this table, the interquartile range (IQR) is Q3 −Q1, where Q1 is the first quartile of the distribution of crystal sizes,
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i.e., the size at which 25% of the crystals are smaller and 75% are larger, and Q3 is the size where 75% are smaller and
25% are larger. The IQR is a convenient measure of the spread in crystal sizes as it is relatively insensitive to outliers
(unlike the standard deviation), and we have outliers in the crystal size, see Figure S12. It is clear that the growth
rates of both polymorphs vary widely between one crystal and another. This is especially true for the α polymorph
where at early times the IQR is larger than the mean.
(a)
0.0
0.5
1.0
1.5
2.0
2.5
0 24 48 72 96 120 144 168
Si
ze
/ 
m
m
Induction time/ h
αnon-needle 
γnon-needle
αneedle
γneedle
(b)
0
2
4
6
8
0 12 24 36 48
Si
ze
/ 
m
m
Induction time/ h
αnon-needle 
γnon-needle
αneedle
γneedle
Figure S13. Here we plot the size of crystals 20 mins after they were initially detected, as a function of the time at which they
nucleated. In (a) the salt concentration is 250 mg/ml, and in (b) it is 90 mg/ml.
C. Growth rate and nucleation time
In the main text we showed that needle-like crystals tend to have faster growth rates. We have also showed that
crystals that nucleate at later times are more likely to be needle-like. It follows that the crystals with longer nucleation
times generally have faster growth rates. As we have discussed, the growth rate of crystals is difficult to quantify for
our data because the growth rate changes with time. Here we plot the size of a crystal 20 mins after it is initially
detected against nucleation time. This is shown in Figure S13. We see that at both salt concentrations, the earliest
nucleating crystals are small at 20 mins.
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Figure S14. For the γ polymorph, we plot the fraction of crystals with a needle-like habit, as a function of the total number of
wells that contain crystals of that polymorph.
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D. Nucleation time and crystal habit
For γ crystals at high salt concentrations, we observe the same correlation between crystal habit and nucleation
time, as we did for the α polymorph (Figure 7). The data for the γ polymorph are shown in Figure S14. We see the
same trend as for the α polymorph, with non-needle-like crystals nucleating at early times, and needle-like crystals
at late times, although the fraction of needles is lower for the γ polymorph. At low salt concentrations, there article
too few γ crystals to make clear statements. For example, at 60 mg/ml and 90 mg/ml there are only six and twelve
γ nucleation events in total, respectively.
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